Abstract10th APACC 2025(Abstract) #33 Twelve-Month (12M) Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Treatment-Experienced People with HIV: A Pooled Analysis from Observational Cohort Studies Across AsiaView Abstract
Abstract10th APACC 2025(Abstract) #32 Informing the Design of Future PrEP Strategies for MSM in Taiwan: A Bayesian Discrete Choice Experiment AnalysisView Abstract
Abstract10th APACC 2025(Abstract) #31 Expanding Access to Oral HIV Pre-Exposure Prophylaxis (PrEP): Implementation Outcomes of a Pharmacy-Led PrEP Service Delivery Model in MalaysiaView Abstract
Abstract10th APACC 2025(Abstract) #30 Improving Mental Health of People Living with HIV Through a Community-Based Antiretroviral Delivery: A Quasi-Experimental Study in CambodiaView Abstract
Abstract10th APACC 2025(Abstract) #29 Cost-Effectiveness of Rapid Versus Delayed ART Initiation in Japan: A Markov Modeling AnalysisView Abstract
Abstract10th APACC 2025(Abstract) #25 The Ongoing Need for HBV Prevention: Vaccination Gaps and Strategies to Improve Outcomes in People Living with HIVView Abstract
Abstract10th APACC 2025(Abstract) #24 Rapid DAA Initiation and HCV Treatment Outcomes among PWH in an Integrated HIV and HCV Care ProgramView Abstract
Abstract10th APACC 2025(Abstract) #23 Key Population-Led Test and Treat for Hepatitis C Virus Infection in Thailand Enables Rapid Initiation of Treatment and Achieved High Virological Success RatesView Abstract
Abstract10th APACC 2025(Abstract) #22 Prevalence of Hepatitis D Virus Infection and Its Impact on the Clinical Efficacy of Antiretroviral Therapy in Patients Co-Infected with Hepatitis B and HIVView Abstract
Abstract10th APACC 2025(Abstract) #28 Stigma Leads to Substance Use among MSM and Transgender Women Living with HIV: Insights from VietnamView Abstract
Abstract10th APACC 2025(Abstract) #27 Preferences of Chinese Caregivers for Their Daughters’ HPV Vaccines and Services: Two Discrete Choice ExperimentsView Abstract
Abstract10th APACC 2025(Abstract) #26 Preliminary Findings of Pay-It-Forward Strategy to Increase HPV Vaccination Rates among Girls Aged 15-18 in China: Pilot Results of a Cluster Randomized Controlled TrialView Abstract
